Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Diagnostics More
OTC Chitosan Gel (ANX-011): A Nasal Gel Formulation for Cold and Flu Treatment that is Commercially Ready More
HIV Indicator Cells (HeLa-CD4-LTR-B-gal. Also known as MAGI cells) with CCR5, CXCR4 More
The Hu-PAC™ Platform: Delivering the Next Generation of Fully Human Therapeutic Antibodies More
Clostridium Difficile Culture and Toxin Production Methods More
pNL Luc AM Pseudotyping Vector: Producing High Titre Pseudooviruses from HIV More
Collagen-based biodegradable matrices for localized drug delivery More
Artificial Human Vagina for Testing Topical Microbicides More
AdVac® Technology: Manufacturing Platform for Vaccines More
1G5 Cell Line for Quantitative and Qualitative Assays of HIV Infection, Related Functions and Inhibitory Treatments More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 40 pages - $500
Jan 2011 - 11 pages - $500
Oct 2009 - 17 pages - $500
Mar 2010 - 414 pages - $690
Jan 2011 - 38 pages - $515
Apr 2010 - 42 pages - $515
Mar 2010 - 30 pages - $515
May 2009 - 32 pages - $515
Jul 2005 - 52 pages - $515
Feb 2009 - 242 pages - $690
Your selection
Browse By
- Industry sector
- Therapeutic device
- Therapeutic medical equipment
- Vision Care
- Therapeutic target
- Bacteria or virus
- Bioterrorism
- Diseases
- Hepatitis (other)
- Nosocomial infections
- Parasitic diseases
- Treatments
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us